Surgalign Holdings and Aziyo Biologics Announce Expanded Distribution Agreement
November 16, 2020 16:05 ET
|
Aziyo Biologics
DEERFIELD, Ill. and SILVER SPRING, Md., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including...
Aziyo Biologics Awarded Breakthrough Technology Contract with Premier Inc.
November 12, 2020 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics to Report Third Quarter 2020 Financial Results on Thursday, November 19, 2020
November 05, 2020 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Announces Pricing of Initial Public Offering
October 07, 2020 20:52 ET
|
Aziyo Biologics
SILVER SPRING, Md., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) today announced the pricing of its initial public offering of 2,941,176 shares of common stock, consisting...
Aziyo Biologics Announces Appointment of Chief Financial Officer
September 28, 2020 17:16 ET
|
Aziyo Biologics
SILVER SPRING, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Announces New Appointments to Board of Directors
September 21, 2020 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Announces Launch of OsteGro® V
June 29, 2020 14:00 ET
|
Aziyo Biologics
SILVER SPRING, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage, regenerative medicine company creating the next generation of differentiated products to...